Navigation Links
As in the US and Europe, the Entrance of Transcatheter Heart Valve Technologies Will Significantly Bolster the Chinese Heart Valve Device Market
Date:12/19/2013

TORONTO, Dec. 19, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the Chinese heart valve device market will exhibit strong growth through 2022. Similar to the more mature United States (US) and European markets, growth will be driven by an aging population as well as the adoption of transcatheter heart valves, although the Chinese market will be further bolstered by strong economic expansion.

(Logo:  http://photos.prnewswire.com/prnh/20130103/MM36799LOGO)

Transcatheter heart valve devices, which are emerging globally to disrupt the traditional heart valve device market, are set to enter the Chinese market in 2014. Both Edwards Lifesciences' SAPIEN and Medtronic's CoreValve transcatheter aortic valve replacement (TAVR) devices are anticipated to enter the market that year, and Edwards Lifesciences may therefore not enjoy the first-mover advantage that it has benefited from in the US. Abbott Laboratories' MitraClip will be the first transcatheter mitral valve repair (TMVR) device to launch in China, reaching the market in 2016. By 2022, TAVR devices will generate $130 million and TMVR devices will generate $50 million in revenue in the country. These procedures will first emerge in Beijing and Shanghai before spreading inland, with procedure volumes concentrated in cities with prestigious medical schools.

"One unique feature in the Chinese market is the high usage of mechanical heart valves," said MRG Analyst Darren Lin. "These valves have fallen out of favor in the US and Europe because they require life-long anticoagulant therapy. However, their low cost has maintained their popularity in China. The use of mechanical heart valves has been further supported by the high prevalence of rheumatic fever in the country, which often leads to mitral regurgitation. Because rheumatic fever commonly afflicts younger individuals, mechanical heart valves are preferred for these patients because of their durability. However, as the rates of rheumatic fever decline and as the Chinese population becomes more affluent, the market will shift in favor of tissue heart valves, similar to other geographies."

Millennium Research Group's Chinese Markets for Heart Valve Devices 2014 report includes procedure, unit, average selling price and revenue information, along with market drivers and limiters and a competitive landscape for heart valve replacement and repair devices in the province-level municipalities, as well as the east coast, central and other regions of China. A current year snapshot is also shown by hospital tier and city tier.

About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources Group company (www.DecisionResourcesGroup.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:



Christopher Comfort
Decision Resources Group
781-993-2597
ccomfort@dresources.com

Alex Jablokow
Millennium Research Group
617-599-8613
ajablokow@mrg.net


'/>"/>
SOURCE Millennium Research Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Innovative Solutions Impact High-End Hospital Information Systems in Europe, Says Frost & Sullivan
2. End Users Desire for Greater Control over Production Processes Increases Adoption of SISs in Europe, Finds Frost & Sullivan
3. Emphasis on X-Ray Quality Spurs Adoption of Computed and Digital Radiography in Europe, Finds Frost & Sullivan
4. Global Image Sensor Market (2013 - 2018) By Technology (CCD, CMOS, Contact IS, Infrared, X-ray, FSI, BSI); Applications (Healthcare, Surveillance, Automobile, Consumer, Defense, Industrial); Geography (North America, Europe, APAC, ROW)
5. High Degree of Disease Prevalence Sustains Diabetes Diagnostics Market in Europe, Finds Frost & Sullivan
6. Anesthesia Equipment and Associated Peripherals: Advanced, Patient-Friendly Devices Will Sustain Market Growth in Europe, States Frost & Sullivan
7. Increasing Minimal Invasive Surgeries to Boost Adoption of Hybrid Operating Rooms in Europe, Says Frost & Sullivan
8. Creative Edge Nutrition, Inc. Announces the Entrance into the Medical Marijuana Sector
9. Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013
10. ISSYS Inc. will showcase its Titan Wireless Implantable Hemodynamic Monitor and its clinical study summary at the 25th Annual Transcatheter Cardiovascular Therapeutics (TCT) Conference (Booth 1638) in San Francisco (October 29 to 31, 2013)
11. Japanese Heart Valve Device Market Growth Will Spike With The Launch of Transcatheter Heart Valves
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)...  Hologic, Inc. (Nasdaq: HOLX ) ... fiscal second quarter ended March 26, 2016.  GAAP ... 41.2%, and non-GAAP diluted EPS of $0.47 increased ... a reported basis, and 6.3% on a constant ... good quarter, highlighted by 14.6% growth in non-GAAP ...
(Date:4/27/2016)... , le 27 Avril 2016 ... d,affaires a progressé de +5% sur le trimestre, ... récurrentes de consommables  Croissance de +16% ... Mauna Kea Technologies (Euronext : MKEA, ... d,endomicroscopie confocale laser, annonce aujourd,hui son chiffre d,affaires ...
(Date:4/27/2016)... -- Elekta today announced that its leading-edge ... focal point of seven scientific presentations at ESTRO 35, ... & Oncology, taking place April 29 - May 3. ... and a high-field MRI scanner with sophisticated software that ... in real time. The MR-linac is designed to improve ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... 2016 , ... Since launching its annual volunteer campaign on ... footwear industry, has broken all previous participation records in its first two weeks ... during the months of April and May, the 2016 Footwear Cares initiative is ...
(Date:4/29/2016)... , ... April 29, 2016 , ... On Tuesday, April ... across the Southeast, celebrated the signature of Gov. Nathan Deal on SB 258, the ... Duncan (R - Cumming), offers a 70% tax credit to individuals and corporations which ...
(Date:4/29/2016)... ... April 29, 2016 , ... Conditions were ideal for Global Lyme Alliance’s ... Sunday, with sunny skies, a light breeze and temperatures in the 60s. Over 400 ... 5k Run and Walk and 1-mile walk were held to increase awareness about ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... student team BioCellection won the $30,000 Perlman Grand Prize of the 2016 Wharton ... Undergraduate Award, the Michelson People’s Choice Award, and the Committee Award for Most ...
(Date:4/29/2016)... , ... April 29, 2016 , ... Melanoma is the deadliest type of skin cancer. ... for the majority of skin cancer deaths. More than 10,000 people are expected to die ... diagnosis is 62, it is the one of the most commonly diagnosed cancers in young ...
Breaking Medicine News(10 mins):